Table 2.

Patient characteristics by presence of ICD after propensity match

FactorNon-ICD Group (n=631)ICD Group (n=631)P Value
Age72.0±10.870.5±11.60.02
Men439 (69.6)428 (67.8)0.50
Black race128 (20.3)111 (17.6)0.22
BMI (kg/m2)28.4±6.128.9±6.00.19
BMI group (kg/m2)0.65
 <18.56 (0.95)4 (0.63)
 18.5–24.9182 (28.8)173 (27.4)
 25–29.9233 (36.9)219 (34.7)
 ≥30206 (32.6)231 (36.6)
 Missing4 (0.63)4 (0.63)
eGFR (ml/min per 1.73 m2)42.2±11.842.8±11.60.33
CKD stage, by eGFR (ml/min per 1.73 m2)0.11
 45–59305 (48.3)303 (48.0)
 30–44219 (34.7)227 (36.0)
 15–2991 (14.4)96 (15.2)
 <1516 (2.5)5 (0.79)
Diabetes186 (29.5)192 (30.4)0.71
Hypertension486 (77.0)488 (77.3)0.89
Congestive heart failure338 (53.6)347 (55.0)0.61
Coronary artery disease338 (53.6)333 (52.8)0.78
Cerebrovascular disease82 (13.0)90 (14.3)0.51
Peripheral vascular disease33 (5.2)31 (4.9)0.80
Coronary revascularization88 (13.9)91 (14.4)0.81
Ventricular arrhythmia18 (2.9)31 (4.9)0.06
Albumin (g/dl)4.0±0.504.0±0.500.04
Hemoglobin (g/dl)12.3±1.912.5±1.90.02
LVEF (%)26.7±9.227.2±8.20.28
Malignancy115 (18.2)99 (15.7)0.23
Use of ACEIs/ARBs573 (90.8)576 (91.3)0.77
Use of statins480 (76.1)490 (77.7)0.50
Use of β-blockers577 (91.4)581 (92.1)0.68
Smoking0.42
 No488 (77.3)506 (80.2)
 Yes51 (8.1)48 (7.6)
 Missing92 (14.6)77 (12.2)
Insurance0.15
 Private129 (20.4)107 (17.0)
 Medicare/Medicaid481 (76.2)509 (80.7)
 Missing21 (3.3)15 (2.4)
  • Data are given as n (%) or means±SD unless otherwise indicated. ICD, implantable cardioverter-defibrillator; BMI: body mass index; LVEF, left ventricular ejection fraction; ACEI/ARB, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker.